Oxford Nanopore Technologies Ltd (ONT) - Total Liabilities

Latest as of December 2025: GBX159.20 Million GBX ≈ $19.37K USD

Based on the latest financial reports, Oxford Nanopore Technologies Ltd (ONT) has total liabilities worth GBX159.20 Million GBX (≈ $19.37K USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Oxford Nanopore Technologies Ltd - Total Liabilities Trend (2012–2025)

This chart illustrates how Oxford Nanopore Technologies Ltd's total liabilities have evolved over time, based on quarterly financial data. See how liquid is Oxford Nanopore Technologies Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.

Oxford Nanopore Technologies Ltd Competitors by Total Liabilities

The table below lists competitors of Oxford Nanopore Technologies Ltd ranked by their total liabilities.

Company Country Total Liabilities
Pintec Technology Holdings Ltd
NASDAQ:PT
USA $496.51 Million
Hanan Mor
TA:HNMR
Israel ILA2.84 Billion
SemiLEDS Corporation
F:6LD1
Germany €14.76 Million
Greentech Metals Ltd
AU:GRE
Australia AU$403.63K
Forgame Holdings Limited
F:FH0
Germany €34.96 Million
RONSHINE CH.HLD.HD-00001
F:1R7
Germany €92.71 Billion
Allurion Technologies, Inc.
NYSE:ALUR
USA $101.07 Million
Dolphin Entertainment Inc
NASDAQ:DLPN
USA $48.64 Million

Liability Composition Analysis (2012–2025)

This chart breaks down Oxford Nanopore Technologies Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see ONT stock market capitalisation.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.56 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.34 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.26 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Oxford Nanopore Technologies Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Oxford Nanopore Technologies Ltd (2012–2025)

The table below shows the annual total liabilities of Oxford Nanopore Technologies Ltd from 2012 to 2025.

Year Total Liabilities Change
2025-12-31 GBX159.20 Million
≈ $19.37K
+2.24%
2024-12-31 GBX155.71 Million
≈ $18.95K
+16.89%
2023-12-31 GBX133.21 Million
≈ $16.21K
+2.21%
2022-12-31 GBX130.33 Million
≈ $15.86K
-5.48%
2021-12-31 GBX137.89 Million
≈ $16.78K
+44.73%
2020-12-31 GBX95.28 Million
≈ $11.59K
+72.58%
2019-12-31 GBX55.21 Million
≈ $6.72K
+70.95%
2018-12-31 GBX32.30 Million
≈ $3.93K
+25.55%
2017-12-31 GBX25.72 Million
≈ $3.13K
+87.69%
2016-12-31 GBX13.71 Million
≈ $1.67K
+65.34%
2015-12-31 GBX8.29 Million
≈ $1.01K
+93.62%
2014-12-31 GBX4.28 Million
≈ $520.87
+38.19%
2013-12-31 GBX3.10 Million
≈ $376.94
+54.29%
2012-12-31 GBX2.01 Million
≈ $244.30
--

About Oxford Nanopore Technologies Ltd

LSE:ONT UK Biotechnology
Market Cap
$13.79 Million
GBX113.30 Billion GBX
Market Cap Rank
#26229 Global
#306 in UK
Share Price
GBX116.50
Change (1 day)
+1.66%
52-Week Range
GBX104.50 - GBX219.00
All Time High
GBX716.00
About

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a novel generation of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequencing technology that allows analysis of DNA or RNA. The company offers MinION Mk 1D, a portable device for DNA and RNA sequencing; and GridION and GridION Q, a compact bench top device that delivers a version… Read more